16α(R),17-[Butylidenbis(oxy)]-11β,21-dihydroxypregna-1,4-dien-3,20-dion
|
|
|
- CAS-Nr.
- 51372-29-3
- Bezeichnung:
- 16α(R),17-[Butylidenbis(oxy)]-11β,21-dihydroxypregna-1,4-dien-3,20-dion
- Englisch Name:
- (r)-budesonide
- Synonyma:
- Dexbudesonide;(R)-Budesonidee;(22R)-Budesonide;(11β,16α)-;Budesonide(S);Budesonide-22;(r)-budesonide;Budesonide-22R;Budesonide(S&R);TriaMcinolone-d5
- CBNumber:
- CB62129545
- Summenformel:
- C25H34O6
- Molgewicht:
- 430.53
- MOL-Datei:
- 51372-29-3.mol
|
16α(R),17-[Butylidenbis(oxy)]-11β,21-dihydroxypregna-1,4-dien-3,20-dion Eigenschaften
- Schmelzpunkt:
- 194-199°C
- Siedepunkt:
- 599.7±50.0 °C(Predicted)
- Dichte
- 1.27±0.1 g/cm3(Predicted)
- storage temp.
- -20°C Freezer
- Löslichkeit
- Chloroform (Slightly), Dichloromethane (Slightly), Methanol (Slightly, Heated)
- pka
- 12.87±0.10(Predicted)
- Aggregatzustand
- Solid
- Farbe
- White to Light Beige
- Stabilität:
- Hygroscopic
Sicherheit
16α(R),17-[Butylidenbis(oxy)]-11β,21-dihydroxypregna-1,4-dien-3,20-dion Chemische Eigenschaften,Einsatz,Produktion Methoden
Chemische Eigenschaften
Light Beige Solid
Verwenden
Budesonide (B689490) epimer R
Trademarks
Entocort (AstraZeneca);
Pulmicort (AstraZeneca); Rhinocort (AstraZeneca).
16α(R),17-[Butylidenbis(oxy)]-11β,21-dihydroxypregna-1,4-dien-3,20-dion Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
16α(R),17-[Butylidenbis(oxy)]-11β,21-dihydroxypregna-1,4-dien-3,20-dion Anbieter Lieferant Produzent Hersteller Vertrieb Händler.
Global( 130)Lieferanten
51372-29-3(16α(R),17-[Butylidenbis(oxy)]-11β,21-dihydroxypregna-1,4-dien-3,20-dion)Verwandte Suche:
Budesonid
16α,17,21-Trihydroxypregna-1,4,9(11)-trien-3,20-dion-21-acetat
Dextromethorphan
Bis[(tert-butyl)(β,3,4-trihydroxyphenethyl)ammonium]sulfat
Procaterol
trans-4-[[(2-Amino-3,5-dibromphenyl)methyl]amino]cyclohexan-1-olhydrochlorid
Ambroxol
Terbutalin
11β,16α,17,21-Tetrahydroxypregna-1,4-dien-3,20-dion
Prednisolon
16α(R),17-[Butylidenbis(oxy)]-11β,21-dihydroxypregna-1,4-dien-3,20-dion
- 16a(r),17-(butylidenebis(oxy))-11b,21-dihydroxypregna-1,4-diene-3,20-dione
- (r)-budesonide
- 16α,17-[(R)-Butylidenebisoxy]-11β,21-dihydroxypregna-1,4-diene-3,20-dione
- (22R)-Budesonide (>90% de)
- (11β,16α)-
- TriaMcinolone-d5
- Budesonide-22R
- Budesonide(S&R)
- Pregna-1,4-diene-3,20-dione,16,17-[(1R)-butylidenebis(oxy)]-11,21-dihydroxy-, (11b,16a)-
- 21-dihydroxypregna-1
- Budesonide(S)
- Budesonide-22
- Budesonide (22R)-Isomer
- Budesonide Impurity 24 ((22R)-Budesonide)
- (r)-budesonide USP/EP/BP
- 16a(R),17-(Butylidenebis(oxy))-11b
- (22R)-BudesonideQ: What is
(22R)-Budesonide Q: What is the CAS Number of
(22R)-Budesonide Q: What is the storage condition of
(22R)-Budesonide Q: What are the applications of
(22R)-Budesonide
- (22R)-Budesonide
- Dexbudesonide
- (R)-Budesonidee
- (6aR,6bS,7S,8aS,8bS,10R,11aR,12aS,12bS)-7-Hydroxy-8b-(2-hydroxyacetyl)-6a,8a-dimethyl-10-propyl-6a,6b,7,8,8a,8b,11a,12,12a,12b-decahydro-1H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-4(2H)-one (Budesonide Impurity)
- Pregna-1,4-diene-3,20-dione, 16,17-[(1R)-butylidenebis(oxy)]-11,21-dihydroxy-, (11β,16α)-
- Budesonide Epimer B
- 51372-29-3
- Intermediates & Fine Chemicals
- Pharmaceuticals
- Steroids
